275 related articles for article (PubMed ID: 32484320)
1. Multifunctional STING-Activating Mn
Zhou M; Wang X; Lin S; Cheng Y; Zhao S; Lin J; Fang Z; Lou Z; Qin L; Wei H
Adv Healthc Mater; 2020 Jul; 9(13):e2000064. PubMed ID: 32484320
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
[TBL] [Abstract][Full Text] [Related]
3. Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy
Hou L; Tian C; Yan Y; Zhang L; Zhang H; Zhang Z
ACS Nano; 2020 Apr; 14(4):3927-3940. PubMed ID: 32298077
[TBL] [Abstract][Full Text] [Related]
4. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
[TBL] [Abstract][Full Text] [Related]
5. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
6. Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia.
Wang X; Huang R; Wu W; Xiong J; Wen Q; Zeng Y; Chen T; Li J; Zhang C; Zhong JF; Yang S; Zhang X
Acta Biomater; 2023 Feb; 157():381-394. PubMed ID: 36375786
[TBL] [Abstract][Full Text] [Related]
7. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
[TBL] [Abstract][Full Text] [Related]
8. Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.
Luo M; Liu Z; Zhang X; Han C; Samandi LZ; Dong C; Sumer BD; Lea J; Fu YX; Gao J
J Control Release; 2019 Apr; 300():154-160. PubMed ID: 30844475
[TBL] [Abstract][Full Text] [Related]
9. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.
Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L
ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.
Mastria EM; Cai LY; Kan MJ; Li X; Schaal JL; Fiering S; Gunn MD; Dewhirst MW; Nair SK; Chilkoti A
J Control Release; 2018 Jan; 269():364-373. PubMed ID: 29146246
[TBL] [Abstract][Full Text] [Related]
11. Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation.
Qian R; Guo Y; Wang R; Wang S; Gao X; Zhu Z; Wang K; Zhu K; Jia B; Chen Y; Wang Z; Ren J; Duan X; Han X
Biomater Res; 2024; 28():0038. PubMed ID: 38868091
[TBL] [Abstract][Full Text] [Related]
12. In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy.
Zhao J; Ma S; Xu Y; Si X; Yao H; Huang Z; Zhang Y; Yu H; Tang Z; Song W; Chen X
Biomaterials; 2021 Jan; 268():120542. PubMed ID: 33249316
[TBL] [Abstract][Full Text] [Related]
13. STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
Wang-Bishop L; Kimmel BR; Ngwa VM; Madden MZ; Baljon JJ; Florian DC; Hanna A; Pastora LE; Sheehy TL; Kwiatkowski AJ; Wehbe M; Wen X; Becker KW; Garland KM; Schulman JA; Shae D; Edwards D; Wolf MM; Delapp R; Christov PP; Beckermann KE; Balko JM; Rathmell WK; Rathmell JC; Chen J; Wilson JT
Sci Immunol; 2023 May; 8(83):eadd1153. PubMed ID: 37146128
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity.
Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X
Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy.
Zhou Q; Zhou Y; Li T; Ge Z
Macromol Biosci; 2021 Aug; 21(8):e2100133. PubMed ID: 34117839
[TBL] [Abstract][Full Text] [Related]
16. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy.
Cao L; Tian H; Fang M; Xu Z; Tang D; Chen J; Yin J; Xiao H; Shang K; Han H; Li X
Biomaterials; 2022 Nov; 290():121856. PubMed ID: 36306685
[TBL] [Abstract][Full Text] [Related]
17. Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity.
Lemos H; Ou R; McCardle C; Lin Y; Calver J; Minett J; Chadli A; Huang L; Mellor AL
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32847988
[TBL] [Abstract][Full Text] [Related]
18. A Manganese-Based Nanodriver Coordinates Tumor Prevention and Suppression through STING Activation in Glioblastoma.
Zhang W; Lu L; Zhu Z; Deng F; Zhang W; Wang F; Zeng P; Shi H; Wang T; Chen Y; Song Y; Liu Y; Kang T; Li K; Mao J; Liu Z; Zhang L
Adv Healthc Mater; 2024 Apr; ():e2400421. PubMed ID: 38576069
[TBL] [Abstract][Full Text] [Related]
19. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia.
Aikins ME; Sun X; Dobson H; Zhou X; Xu Y; Lei YL; Moon JJ
J Control Release; 2024 Apr; 368():768-779. PubMed ID: 38492861
[TBL] [Abstract][Full Text] [Related]
20. Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive.
Li Q; Chen Q; Yang X; Zhang Y; Lv L; Zhang Z; Zeng S; Lv J; Liu S; Fu B
J Nanobiotechnology; 2022 Feb; 20(1):84. PubMed ID: 35177088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
